Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FSZ22
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on August 15, 2025, carries a ceiling value of $16,249.95 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. The place of performance is the vendor's facility in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the open federal marketplace.
This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the DLA's SPE2DB program, enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities. Stelara, a biologic medication used to treat autoimmune conditions, represents one of the specialty pharmaceutical products available through this contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FSZ22?
SPE2DB25FSZ22 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FSZ22 worth?
The government has obligated $16,250 on SPE2DB25FSZ22.
Is contract SPE2DB25FSZ22 an order under another contract?
Yes. SPE2DB25FSZ22 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ22 competed?
The extent of competition for SPE2DB25FSZ22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award